Elevated interleukin-18 and skewed Th1:Th2 immune response in lupus nephritis

被引:0
|
作者
Xiaoqian Liu
Chunde Bao
Dawei Hu
机构
[1] Shanghai Jiao Tong University School of Medicine,Shanghai Institute of Rheumatology, Renji Hospital
[2] Shanghai University of Traditional Chinese Medicine,Department of Rheumatology, Shuguang Hospital
来源
关键词
Lupus nephritis; Interleukin-18; Th1:Th2; IFN-γ: IL-4;
D O I
暂无
中图分类号
学科分类号
摘要
There is evidence that interleukin-18 plays a role in lupus nephritis (LN). Since interleukin -18 (IL-18) promotes polarization of the immune response toward Th1, we investigated level of IL-18 and assessed the phenotypic distribution of Th1 and Th2 type cells in LN. A predominance of Th1 type (IFN-γ+) cells and significant correlations with serum IL-18 was seen in the patients with LN compared to healthy controls. Although most patients were treated with high dosage of glucocorticoid and other immunosuppressive agents, higher level of IL-18 was found in both serum and glomeruli. However, there was no paralleled upregulation of its gene expression in peripheral blood mononuclear cells. Our findings indicate that the elevated IL-18 should be a symbol of disease activity and play a major role in the pathogenesis of LN by promoting cytokine imbalance towards Th1 type immune response. We conclude that patients with LN would benefit from it while the bioactivity of this cytokine was effectively counteracted.
引用
收藏
页码:223 / 229
页数:6
相关论文
共 50 条
  • [31] Th1/Th2 cytokine profile of the immune response in limb component transplantation
    Tung, TH
    Mohanakumar, T
    Mackinnon, SE
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2005, 116 (02) : 557 - 566
  • [32] Th1/Th2 immune response in lung fibroblasts in interstitial lung disease
    Sumida, Atsushi
    Hasegawa, Yoshinori
    Okamoto, Masakazu
    Hashimoto, Naozumi
    Imaizumia, Kazuyoshi
    Yatsuya, Hiroshi
    Yokoi, Toyoharu
    Takagi, Kenzo
    Shimokata, Kaoru
    Kawabe, Tsutomu
    ARCHIVES OF MEDICAL RESEARCH, 2008, 39 (05) : 503 - 510
  • [33] Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis
    Elizabeth Torres-Morales
    Laura Taborda
    Nestor Cardona
    Alejandra De-la-Torre
    Juan Carlos Sepulveda-Arias
    Manuel Alfonso Patarroyo
    Jorge Enrique Gomez-Marin
    Medical Microbiology and Immunology, 2014, 203 : 315 - 322
  • [34] Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis
    Torres-Morales, Elizabeth
    Taborda, Laura
    Cardona, Nestor
    De-la-Torre, Alejandra
    Carlos Sepulveda-Arias, Juan
    Alfonso Patarroyo, Manuel
    Enrique Gomez-Marin, Jorge
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2014, 203 (05) : 315 - 322
  • [35] Cellular immune response and Th1/Th2 cytokines in human neurocysticercosis:: Lack of immune suppression
    Medina-Escutia, E
    Morales-López, Z
    Proaño, JV
    Vázquez, J
    Bermúdez, V
    Ortiz-Navarrete, V
    Madrid-Marina, V
    Laclette, JP
    Correa, D
    JOURNAL OF PARASITOLOGY, 2001, 87 (03) : 587 - 590
  • [36] Ethanol consumption inhibits Th1 but not Th2 skewed contact hypersensitivity responses
    Brandi, Rhonda
    Stottlemyer, J. Mark
    Cline, Rachel
    Falo, Louis, Jr.
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [37] Interleukin-2 is produced by both Th1 and Th2 cells
    Prussin, C
    Foster, B
    Metcalfe, DD
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (01) : 466 - 466
  • [38] Reduced host resistance and Th1 response to Cryptococcus neoformans in interleukin-18 deficient mice
    Kawakami, K
    Koguchi, Y
    Qureshi, MH
    Kinjo, Y
    Yara, S
    Miyazato, A
    Kurimoto, M
    Takeda, K
    Akira, S
    Saito, A
    FEMS MICROBIOLOGY LETTERS, 2000, 186 (01) : 121 - 126
  • [39] A distinct Th1 immune response precedes the described Th2 response in islet xenograft rejection
    Krook, H
    Hagberg, A
    Song, ZS
    Landegren, U
    Wennberg, L
    Korsgren, O
    DIABETES, 2002, 51 (01) : 79 - 86
  • [40] Th1, Th2, and Th17 cytokines in systemic lupus erythematosus
    Muhammad Yusoff, Farhana
    Wong, Kah Keng
    Mohd Redzwan, Norhanani
    AUTOIMMUNITY, 2020, 53 (01) : 8 - 20